![1]()
News
Hospital infections top WHO’s list of priority pathogens
April 25, 2017
WHO is urging governments to focus antibiotic research efforts on a list of urgent bacterial threats, topped by several increasingly powerful superbugs.
News
Guideline for reversal of antithrombotics in intracranial hemorrhage
April 25, 2017
Clinical Question: What is the current guideline for reversal of antithrombotics in intracranial hemorrhage (ICH)?
News
Elimination of urine culture screening prior to elective joint arthroplasty
April 24, 2017
What is the clinical impact of implementing a policy to no longer process urine specimens for perioperative screening in patients undergoing elective joint arthroplasty (EJA)?
![1]()
News
In the lit: Short takes
April 23, 2017
A brief roundup of HM-centric research
News
Risks are reduced when angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers are held before noncardiac surgery
April 22, 2017
Is withholding angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARBs) prior to noncardiac surgery associated with a lower risk of a 30-day composite outcome of all-cause death, myocardial injury after noncardiac surgery, and stroke when compared with continuing them on the day of surgery?
News
Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding
April 19, 2017
What are the accuracy and clinical utility of risk scoring systems in the assessment of patients with upper gastrointestinal (GI) bleeding?
![1]()
News
Patient-to-intensivist ratios can influence patient mortality
April 19, 2017
Is there variation in patient-to-intensivist ratios (PIR) across ICUs, and does that ratio affect hospital mortality?
![1]()
News
It’s been a good year for heart failure research … mostly
April 13, 2017
WASHINGTON – The highs ... and the lows.
![1]()
Article
Procalcitonin guidance improves antibiotic stewardship
April 13, 2017
Use of the procalcitonin assay has been shown to reduce antibiotic utilization without an increase in adverse outcomes.
News
Uptake of new heart failure drugs slow despite guidelines
April 5, 2017
Ivabradine and sacubitril/valsartan reduce mortality and hospitalizations.
